A 62-year-old woman with R/R DLBCL after 2 lines of systemic therapy

This patient case has been developed with the assistance of Dr. John Kuruvilla (Princess Margaret Cancer Centre, Toronto, ON, Canada). This program was supported by an educational grant from Bristol Myers Squibb Canada Co.

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different labeling according to geographical location; within Canada, full prescribing information is available from Health Canada.

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended only for healthcare professionals registered to practice in Canada. To proceed, please confirm that you are a healthcare professional practicing in Canada.

Modules

  • A 62-year-old woman with R/R DLBCL after 2 lines of systemic therapy

Previous
Previous

CMV reactivation post-allogeneic HSCT in a patient with GvHD, neutropenia, and renal failure

Next
Next

Guiding chemotherapy treatment decisions in patients with early-stage breast cancer